fleming 156.25 mg/ 5 ml powder for oral suspension
paradigm pharma (philippines) corporation; distributor: metro drug, inc. - co-amoxiclav - powder for oral suspension - 156.25 mg/ 5 ml
fasgesic 400 mg soft-gelatin capsule
paradigm pharma (philippines ) corporation - ibuprofen - soft-gelatin capsule - 400 mg
fleming 1 g film- coated tablet
paradigm pharma (philippines) corporation; distributor: metro drug, inc. - co-amoxiclav - film- coated tablet - 1 g
paradigm arylex active herbicide
corteva agriscience australia pty ltd - halauxifen-methyl; florasulam - water dispersible granule - halauxifen-methyl active 200.0 g/kg; florasulam triazolopyrimidine active 200.0 g/kg - herbicide
anadex 1mg film-coated tablet
paradigm pharma (phils.) corporation - anastrozole - film-coated tablet - 1mg
paradigm
corteva agriscience new zealand limited - florasulam; halauxifen-methyl - florasulam 200 g/kg; halauxifen-methyl 200 g/kg - herbicide
bezam 5mg tablet
paradigm pharma (thailand) co.; importer: littman drug corporation; distributor: littman drug corporation - amlodipine (as besilate) - tablet - 5mg
paradigm spine coflex interlaminar implant
transmedic pte ltd - orthopaedics - the coflex implant is intended for permanent implantation between the spinous processes of 1 or 2 lumbar motion segments and controls segmental motion in cases of lumbar stenosis or mild degenerative instability. the coflex implant may also be used in up to 2 lumbar motion segments adjacent to fused level(s). indications include radiographically confirmed moderate to severe stenosis, isolated to 1 or 2 levels, in the region of l1 to l5 in a patient with or without concomitant low back pain, including conditions such as stable grade 1 spondylolisthesis
paradigm spine dci™ dynamic cervical implant
transmedic pte ltd - orthopaedics - the dci implant is intended for permanent implantation between the anterior cervical disc space at 1 to 3 levels from c3 to c7 in skeletally mature patients and controls segmental motion in cases of cervical disc herniation, cervical degenerative disc disease (ddd) and cervical canal stenosis (central or foraminal) with or without myeloradiculopathy in patients with or without neck pain.
paradigm spine hps™ hybrid performance system
transmedic pte ltd - orthopaedics - indicated for skeletally mature patients with degenerative disc disease (ddd) or for painful segmental degeneration of the disc and/or facet joints. semi-rigid stabilization use of the rod coupler is indicated for segmental degeneration or minor segmental instability (disc and/or facet joints) including grade 1 spondylolisthesis. fusion use of the fusion components are indicated for monosegmental or multisegemental stabilization of the thoracic and lumbar spine for supporting fusion. fusion may be necessary due to: • degenerative instability • pseudarthrosis / delayed union • post-discectomy syndrome • spondylolisthesis • degenerative lumbar scoliosis • lumbar spinal canal stenosis • fracture • tumor • long idiopathic or congenital deformities